Page last updated: 2024-11-07

carbachol and Choriocarcinoma

carbachol has been researched along with Choriocarcinoma in 2 studies

Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.

Choriocarcinoma: A malignant metastatic form of trophoblastic tumors. Unlike the HYDATIDIFORM MOLE, choriocarcinoma contains no CHORIONIC VILLI but rather sheets of undifferentiated cytotrophoblasts and syncytiotrophoblasts (TROPHOBLASTS). It is characterized by the large amounts of CHORIONIC GONADOTROPIN produced. Tissue origins can be determined by DNA analyses: placental (fetal) origin or non-placental origin (CHORIOCARCINOMA, NON-GESTATIONAL).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldman, PS1
Nathanson, NM1
Barbieri, RL1
Gochberg, J1
Ryan, KJ1

Other Studies

2 other studies available for carbachol and Choriocarcinoma

ArticleYear
Differential role of the carboxyl-terminal tyrosine in down-regulation and sequestration of the m2 muscarinic acetylcholine receptor.
    The Journal of biological chemistry, 1994, Jun-03, Volume: 269, Issue:22

    Topics: Amino Acid Sequence; Animals; beta-Galactosidase; Carbachol; Cell Line; Cell Membrane; Choriocarcino

1994
Nicotine, cotinine, and anabasine inhibit aromatase in human trophoblast in vitro.
    The Journal of clinical investigation, 1986, Volume: 77, Issue:6

    Topics: Anabasine; Androstenedione; Aromatase Inhibitors; Carbachol; Cells, Cultured; Choriocarcinoma; Cotin

1986